Skip to main content
Livermore
Livermore
中文EN

Bone Biologics Corp

BBLGW
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001419554

No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $400.1K in total; no superinvestor holds it.

Other share classesBBLG

13F holders, Q2 2026

Institutional positions in Bone Biologics Corp as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
2
0 vs. Q1 2026
Shares held
26.9K
−3.26K (−10.8%) vs. Q1 2026
Total value
$400.1K
−$289.8K (−42.0%) vs. Q1 2026
New holders
0
1 more added
Sold out
0
1 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BBLGW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 2 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 4 institutionsQ1 2022: 5 institutionsQ2 2022: 5 institutionsQ3 2022: 5 institutionsQ4 2022: 3 institutionsQ1 2023: 5 institutionsQ2 2023: 2 institutionsQ3 2023: 3 institutionsQ4 2023: 1 institutionQ1 2024: 3 institutionsQ2 2024: 2 institutionsQ3 2024: 2 institutionsQ4 2024: 2 institutionsQ1 2025: 3 institutionsQ2 2025: 3 institutionsQ3 2025: 3 institutionsQ4 2025: 2 institutionsQ1 2026: 2 institutionsQ2 2026: 2 institutions
Value heldQ2 2026: $400.1K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $246.0KQ1 2022: $134.0KQ2 2022: $62.0KQ3 2022: $42.0KQ4 2022: $3.11KQ1 2023: $8.27KQ2 2023: $805Q3 2023: $324.4KQ4 2023: $44.9KQ1 2024: $570.4KQ2 2024: $2.02MQ3 2024: $1.82MQ4 2024: $1.48MQ1 2025: $557.3KQ2 2025: $537.0KQ3 2025: $357.7KQ4 2025: $550.5KQ1 2026: $689.9KQ2 2026: $400.1K
Institutions holding BBLGW and their total value by quarter
QuarterHoldersValue
Q2 20262$400.1K
Q1 20262$689.9K
Q4 20252$550.5K
Q3 20253$357.7K
Q2 20253$537.0K
Q1 20253$557.3K
Q4 20242$1.48M
Q3 20242$1.82M
Q2 20242$2.02M
Q1 20243$570.4K
Q4 20231$44.9K
Q3 20233$324.4K
Q2 20232$805
Q1 20235$8.27K
Q4 20223$3.11K
Q3 20225$42.0K
Q2 20225$62.0K
Q1 20225$134.0K
Q4 20214$246.0K
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Bone Biologics Corp; share changes are against Q1 2026.

Institutions holding BBLGW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC26,398$396.0K0.00%−3,354−11.3%Reduced
UBS Group AG513$4.10K0.00%+91+21.6%Added